EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Recent Advances in Mesoporous Silica Nanoparticle-Mediated Drug Delivery for Breast Cancer Treatment

Ruma Rani iD, Parth Malik, Sunena Dhania, Tapan Kumar Mukherjee

Pharmaceutics · 09.01.2023 · 15 (1) · 227

DOI: 10.3390/pharmaceutics15010227 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Pharmaceutics, online erschienen am 09.01.2023. Verfasst von Ruma Rani und 3 weiteren Autor:innen. Beteiligte Einrichtung: ICAR-National Research Centre on Equines, Hisar 125001, Haryana, India. Die Arbeit wurde bisher 61-mal zitiert (Crossref) und nennt 212 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Breast cancer (BC) currently occupies the second rank in cancer-related global female deaths. Although consistent awareness and improved diagnosis have reduced mortality in recent years, late diagnosis and resistant response still limit the therapeutic efficacy of chemotherapeutic drugs (CDs), leading to relapse with consequent invasion and metastasis. Treatment with CDs is indeed well-versed but it is badly curtailed with accompanying side effects and inadequacies of site-specific drug delivery. As a result, drug carriers ensuring stealth delivery and sustained drug release with improved pharmacokinetics and biodistribution are urgently needed. Core–shell mesoporous silica nanoparticles (MSNPs) have recently been a cornerstone in this context, attributed to their high surface area, low density, robust functionalization, high drug loading capacity, size–shape-controlled functioning, and homogeneous shell architecture, enabling stealth drug delivery. Recent interest in using MSNPs as drug delivery vehicles has been due to their functionalization and size–shape-driven versatilities. With such insights, this article focuses on the preparation methods and drug delivery mechanisms of MSNPs, before discussing their emerging utility in BC treatment. The information compiled herein could consolidate the database for using inorganic nanoparticles (NPs) as BC drug delivery vehicles in terms of design, application and resolving post-therapy complications.

Schlagwörter

Stichwörter der Autor:innen

biodistributionbreast cancerchemotherapeutic drugsdrug deliverymesoporous silica nanoparticlesmetastasispharmacokineticssustained release

Autor:innen und Institutionen

  • ICAR-National Research Centre on Equines, Hisar 125001, Haryana, India.
  • School of Chemical Sciences, Central University of Gujarat, Gandhinagar 382030, Gujarat, India.
  • Department of Bio & Nano Technology, Guru Jambheshwar University of Science and Technology, Hisar 125001, Haryana, India.
  • Institute of Biotechnology (AIB), Amity University, Noida 201313, Uttar Pradesh, India.

ORCID-Profile: Ruma Rani

Zitieren

APA

Rani, R., Malik, P., Dhania, S., & Mukherjee, T. K. (2023). Recent Advances in Mesoporous Silica Nanoparticle-Mediated Drug Delivery for Breast Cancer Treatment. Pharmaceutics, 15(1), 227. https://doi.org/10.3390/pharmaceutics15010227

Vancouver

Rani R, Malik P, Dhania S, Mukherjee TK. Recent Advances in Mesoporous Silica Nanoparticle-Mediated Drug Delivery for Breast Cancer Treatment. Pharmaceutics. 2023;15(1):227. doi:10.3390/pharmaceutics15010227

BibTeX
@article{Rani2023,
  author = {Rani, Ruma and Malik, Parth and Dhania, Sunena and Mukherjee, Tapan Kumar},
  title = {Recent Advances in Mesoporous Silica Nanoparticle-Mediated Drug Delivery for Breast Cancer Treatment},
  journal = {Pharmaceutics},
  year = {2023},
  volume = {15},
  number = {1},
  pages = {227},
  doi = {10.3390/pharmaceutics15010227}
}
Kostenlos starten →